Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$40,434,773
+$4,917,569 QoQ
Shares Held
160,685
-1.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#417
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $269,326,033 across 9 Drug Manufacturers - General names. ABBV ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
40,766 | $48,895,967 | |
| 2 | JNJ |
Johnson & Johnson
|
184,122 | $46,761,464 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
160,685 | $40,434,773 | |
| 4 | MRK |
Merck & Co., Inc.
|
274,491 | $35,272,093 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
520,919 | $30,015,352 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
181,879 | $22,978,592 | |
| 7 | AMGN |
Amgen Inc
|
62,656 | $22,688,990 | |
| 8 | PFE |
Pfizer Inc
|
477,198 | $11,490,927 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,434,773 | 160,685 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $35,517,204 | 163,305 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $36,228,003 | 158,554 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $35,519,856 | 153,407 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $31,208,476 | 168,131 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $26,505,537 | 126,506 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $26,696,404 | 150,233 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $31,543,085 | 159,728 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $33,544,852 | 195,574 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $37,776,280 | 207,448 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $34,702,587 | 223,931 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $34,947,266 | 234,451 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $31,919,692 | 236,916 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $38,299,320 | 240,317 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $38,359,911 | 237,361 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $34,201,136 | 254,833 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $37,882,594 | 247,340 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $43,710,854 | 269,637 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $19,051,186 | 140,703 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,967,458 | 36,780 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,466,045 | 30,771 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $2,596,458 | 24,232 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,692,253 | 30,737 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,017,758 | 30,737 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,661,773 | 34,936 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||